Cameron Gray
Founder at Itolerance, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frances L. Johnson | M | - |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | 16 years |
| Peter Kiener | M | 72 |
Itolerance, Inc.
 Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | 8 years |
| Frank Morich | M | 69 |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | 6 years |
| Michael K. Schultz | M | - |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | 16 years |
| Daniel Passeri | M | 63 | 8 years | |
| Kerri-Ann Millar | F | 54 | 7 years | |
| Fred Driscoll | M | 73 | 6 years | |
| Colin Sandercock | M | 67 | 7 years | |
| Eleanor Ramos | M | 67 | 7 years | |
| Harold T. Shapiro | M | 89 |
Princeton University
| 36 years |
| Anthony Japour | M | 64 |
Itolerance, Inc.
Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | - |
| Anish Suri | M | 50 | 6 years | |
| Curtis R. Nelson | M | - |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | - |
| Stephen Pacala | M | 67 |
Princeton University
| 32 years |
| Matteo Levisetti | M | 55 | 3 years | |
| Alex Rabiee | M | - | 5 years | |
| Charles Link | M | 64 |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | 3 years |
| Cecilia Elena Rouse | M | 60 |
Princeton University
| 32 years |
| Douglas Jacobstein | M | - | 5 years | |
| Thomas Raffin | M | 77 |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA. | - |
| David Brautigan | M | - |
University of Virginia
| 30 years |
| Burt Malkiel | M | 90 |
Princeton University
| 36 years |
| C. Wilson McNeely | M | - |
University of Virginia
| 30 years |
| Carl P. Zeithaml | M | 74 |
University of Virginia
| 27 years |
| Justin Vogel | M | 52 | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Franciscus L. Diaba | M | 51 | 3 years | |
| Mark Kevin Hunter | M | 52 | 1 years | |
| Robert C. Clifford | M | - |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Public Ventures LLC is a registered broker-dealer headquartered in Dallas, Texas. The firm was founded by Christopher Marlett and Anthony DiGiandomenico in 1997. They are a wholly-owned subsidiary of MDB Capital Holdings LLC. Public Ventures offers Go-to-Market Strategy, Market Assessments, Revenue Generation and Product Strategy for technology companies that targets the Public Sector. | 4 years |
| Andrew Trees | M | - |
Princeton University
University of Virginia
| 9 years |
| Wayne Pisano | M | 69 | 5 years | |
| Barry Simon | M | 59 | - | |
| Anthony DiGiandomenico | M | 57 | 5 years | |
| Scott B Crenshaw | M | - |
University of Virginia
| 6 years |
| Patrick J. Sweeney | M | - |
University of Virginia
| 2 years |
| Christopher D. Ray | M | 54 |
University of Virginia
| 7 years |
| Rachel W. Sheridan | F | - |
University of Virginia
| 8 years |
| Andrew Uribe | M | 67 | 3 years | |
| Vassilios Niko Nicopoulos | M | - |
Princeton University
| 5 years |
| Edward W. Elmore | M | - |
University of Virginia
| 7 years |
| Ted S. Hollifield | M | - |
University of Virginia
| 3 years |
| Avery Catlin | M | 75 | 5 years | |
| Robert D. Stock | M | - |
Princeton University
| 4 years |
| Erin McCormack | F | - |
University of Virginia
| 4 years |
| Alex H. Bocock | M | - |
Princeton University
University of Virginia
| 7 years |
| Adam Safir | M | 51 |
University of Virginia
| 7 years |
| Stewart L. McDowell | F | - |
Princeton University
University of Virginia
| 8 years |
| Gary Alan Schuman | M | 56 | 3 years | |
| Matthew Cutts | M | - |
University of Virginia
| 7 years |
| Steven McKnight | M | 75 | 4 years | |
| Andrew Schwab | M | - |
University of Virginia
| 11 years |
| Frank Rotman | M | - |
University of Virginia
| 5 years |
| Chris B. Norton | M | - |
University of Virginia
| 7 years |
| Chris G. Lanning | M | - |
University of Virginia
| 8 years |
| Peter Rathjens | M | 65 |
Princeton University
| 4 years |
| Neil Carter | M | - |
University of Virginia
| 11 years |
| Wendy Young | M | - |
Princeton University
| 4 years |
| Marc Conner | M | - |
Princeton University
| 4 years |
| Peter C. M. McWilliams | M | - |
Princeton University
| 3 years |
| Jeffrey Bluestone | M | 70 | 3 years | |
| Rodolfo J. Chaparro | M | - | 7 years | |
| Aaron Fletcher | M | 44 | 4 years | |
| Yannis A. Koskosidis | M | - |
Princeton University
| 4 years |
| David Clark | M | 47 |
University of Virginia
| 5 years |
| Tamar Howson | F | 75 | 3 years | |
| Paul Conley | M | 56 |
University of Virginia
| 5 years |
| Christopher G. Loos | M | - |
University of Virginia
| 6 years |
| William T. Burke | M | - |
Princeton University
University of Virginia
| 8 years |
| Kevin A. Davis | M | - |
Princeton University
| 4 years |
| Nicholas Tramontana | M | - |
University of Virginia
| 2 years |
| Alfred L. Browne | M | - |
University of Virginia
| 3 years |
| J.C. Schweingrouber | M | - |
University of Virginia
| 4 years |
| Amar K. Bhatia | M | - |
University of Virginia
| 4 years |
| Rob Garr | M | - |
University of Virginia
| 4 years |
| Jason Love | M | - |
University of Virginia
| 4 years |
| Taylor Davidson | M | - |
University of Virginia
| 3 years |
| Michael Alpert | M | - |
University of Virginia
| 4 years |
| James T. Fang | M | - |
University of Virginia
| 4 years |
| Jennifer Smith | F | - |
University of Virginia
| 4 years |
| Scott Spencer | M | - |
University of Virginia
| 4 years |
| Edward Sung Soo Han | M | - |
University of Virginia
| 2 years |
| Doug Rao | M | - |
University of Virginia
| 4 years |
| Randolph A. Moore | M | - |
University of Virginia
| 3 years |
| Mark A. Riser | M | - |
University of Virginia
| 2 years |
| Richard John Gates | M | 52 |
University of Virginia
| 4 years |
| Wolf Joffe | M | - |
University of Virginia
| 4 years |
| Taz Turner | M | - |
University of Virginia
| 4 years |
| Adam G. Raper | M | - |
University of Virginia
| 3 years |
| Mark S. Goodman | M | - |
University of Virginia
| 4 years |
| James Taylor | M | 57 |
University of Virginia
| 3 years |
| Rick Inder Singh | M | - |
University of Virginia
| 4 years |
| Jennie Tsai | F | - |
University of Virginia
| 4 years |
| Taylor Dunn McGowan | M | - |
University of Virginia
| 4 years |
| Sid Nadkarni | M | - |
University of Virginia
| 4 years |
| Alec John Henry | M | - |
University of Virginia
| 4 years |
| Troy Kenyon | M | - |
University of Virginia
| 2 years |
| Roy Notowitz | M | - |
University of Virginia
| 3 years |
| Greyson Pryor Williams | M | - |
University of Virginia
| 4 years |
| Ryan Patrick Kenny Lentell | M | - |
University of Virginia
| 4 years |
| James Armin West | M | - |
University of Virginia
| 4 years |
| Daniel W. Pike | M | - |
University of Virginia
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cameron Gray
- Personal Network
